Bladder Cancer
📧 Sign up to get email alerts when something new happens for Bladder Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-08-03Clinical Trial Update: OH2 Oncolytic Viral Therapy in Advanced Bladder Cancer [Phase 2]
Phase 2 trial of OH2 oncolytic viral therapy for advanced bladder cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2025-08-03Clinical Trial Update: Prophylactic Antibiotics for Urinary Tract Infections After Robot-Assisted Radical Cystectomy [Phase 4]
Phase 4 clinical trial evaluating prophylactic antibiotics to prevent urinary tract infections after robot-assisted radical cystectomy has c…
-
CLINICAL_TRIALS trial_result · 2025-07-30Clinical Trial Update: Radical Cystectomy Versus Tri-Modal Therapy for Treatment of cT2N0M0 Urinary Bladder Transitional Cell Carcinoma [NA]
Completed clinical trial comparing radical cystectomy versus tri-modal therapy for cT2N0M0 bladder cancer (transitional cell carcinoma of th…
-
CLINICAL_TRIALS trial_result · 2025-07-30Clinical Trial Update: Impact of Remimazolam on Prognosis After Bladder Cancer Surgery [Phase 4]
A Phase 4 clinical trial is evaluating whether remimazolam used during bladder cancer surgery influences prognosis; recruitment is ongoing.
-
CLINICAL_TRIALS trial_result · 2025-07-28Clinical Trial Update: Celecoxib With Chemotherapy in Localized, Muscle-Invasive Bladder Cancer [Phase 1]
Phase 1 study evaluating celecoxib with chemotherapy for localized, muscle-invasive bladder cancer has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-07-28Clinical Trial Update: Enfortumab Vedotin Plus Pembrolizumab for the Treatment of Locally Advanced or Metastatic Bladder Cancer of Variant Histology [Phase 2]
Phase 2 study evaluating Enfortumab Vedotin plus Pembrolizumab for locally advanced or metastatic bladder cancer with variant histology. The…
-
CLINICAL_TRIALS trial_result · 2025-07-25Clinical Trial Update: A Study of Evorpacept (ALX148) With Enfortumab Vedotin for Subjects With Urothelial Carcinoma (ASPEN-07) [Phase 1]
Phase 1 study ASPEN-07 evaluating Evorpacept (ALX148) with Enfortumab Vedotin for urothelial carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2025-07-24Clinical Trial Update: Study of Combined VisioCyt Test and FGFR3 Mutations on a Urinary Sample to Diagnose Bladder Tumors [NA]
A completed clinical trial evaluating a combined VisioCyt urinary test and FGFR3 mutation analysis to diagnose bladder cancer.
-
CLINICAL_TRIALS trial_result · 2025-07-22Clinical Trial Update: Relationship Between Tumor Mutation Burden and Predicted Neo-antigen Burden in Patients With Advanced Melanoma or Bladder Cancer Treated With Nivolumab or Nivolumab Plus Ipilimumab (CA209-260) [Phase 2]
Phase 2 study CA209-260 in advanced melanoma and bladder cancer examined the relationship between tumor mutation burden and predicted neoant…
-
CLINICAL_TRIALS trial_result · 2025-07-20Clinical Trial Update: A Home-based Lifestyle Intervention for Optimizing Surgical Outcomes Among Urinary Bladder Cancer Patients [NA]
Completed clinical trial evaluating a home-based lifestyle intervention to optimize surgical outcomes for bladder cancer patients undergoing…
-
CLINICAL_TRIALS trial_result · 2025-07-11Clinical Trial Update: INCB106385 Alone or in Combination With Immunotherapy in Advanced Solid Tumors [Phase 1]
A Phase 1 trial of INCB106385, alone or with immunotherapy, in advanced solid tumors has completed. The study includes multiple indications …
-
CLINICAL_TRIALS trial_result · 2025-07-04Clinical Trial Update: A Study of Autogene Cevumeran (RO7198457) as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Tumors [Phase 1]
This Phase 1 trial assesses Autogene Cevumeran (RO7198457) as a single agent and in combination with atezolizumab across multiple locally ad…
-
CLINICAL_TRIALS trial_result · 2025-06-06Clinical Trial Update: Basal Tumours in Bladder Cancer, Response to chemoTherapy
A completed clinical trial update focusing on basal tumors in bladder cancer and their response to chemotherapy.
-
CLINICAL_TRIALS trial_result · 2025-06-05Clinical Trial Update: Multicohort Phase II Trial of sEphB4-HSA+Pembrolizumab in Solid Tumors [Phase 2]
This is a Phase II multicohort trial assessing sEphB4-HSA in combination with pembrolizumab for solid tumors; the study is currently active …
-
CLINICAL_TRIALS trial_result · 2025-05-31Clinical Trial Update: Deep Learning Radiomics Model for Predicting Post-cystectomy Outcome in Muscle Invasive Bladder Cancer
A clinical trial is evaluating a deep learning radiomics model to predict outcomes after cystectomy in patients with muscle-invasive bladder…
-
CLINICAL_TRIALS trial_result · 2025-05-29Clinical Trial Update: Study of NGM120 in Subjects With Advanced Solid Tumors, Pancreatic Cancer, and Prostate Cancer Using Combination Therapy [Phase 1, Phase 2]
This update reports results from a Phase 1/2 study of NGM120 in combination therapy for patients with advanced solid tumors, including pancr…
-
CLINICAL_TRIALS trial_result · 2025-05-21Clinical Trial Update: Dose-Escalation of MNPR-101-PCTA-177Lu in Solid Tumors [Phase 1]
Phase 1 dose-escalation study of MNPR-101-PCTA-177Lu in solid tumors is currently recruiting across multiple cancer indications.
-
CLINICAL_TRIALS trial_result · 2025-05-15Clinical Trial Update: Nutrition Therapy in Improving Immune System in Patients With Bladder Cancer That Can Be Removed by Surgery [Phase 3]
Phase 3 trial evaluating nutrition therapy to boost immune function in bladder cancer patients eligible for surgical removal; results have b…
-
CLINICAL_TRIALS trial_result · 2025-05-13Clinical Trial Update: Phase 1/2 Study of APR-246 in Combination With Pembrolizumab in Subjects With Solid Tumor Malignancies [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating APR-246 in combination with pembrolizumab in solid tumors has completed enrollment with results posted…
-
CLINICAL_TRIALS trial_result · 2025-04-27Clinical Trial Update: Associations Between Chemotherapy-Induced Nausea in Patients With Genitourinary, Sarcoma or Melanoma Cancers and Changes in Gut Microbiome: Potential for Precision Therapeutics
A terminated Mayo Clinic trial investigated associations between chemotherapy-induced nausea in genitourinary, sarcoma, and melanoma cancers…
-
CLINICAL_TRIALS trial_result · 2025-04-25Clinical Trial Update: Afatinib in Advanced Refractory Urothelial Cancer [Phase 2]
Phase 2 trial of afatinib in advanced refractory urothelial cancer was terminated, with results posted.
-
CLINICAL_TRIALS trial_result · 2025-04-23Clinical Trial Update: Intraoperative vs. Postoperative Intravesical Epirubicin Instillation for Prevention of Bladder Recurrence in High-Risk Upper Urinary Tract Urothelial Carcinoma
A completed clinical trial comparing intraoperative versus postoperative intravesical epirubicin to prevent bladder recurrence in high-risk …
-
CLINICAL_TRIALS trial_result · 2025-04-23Clinical Trial Update: PUBMIC (Prophylactic Use of Biologic Mesh in Ileal Conduit) [NA]
This update notes that the PUBMIC trial evaluating prophylactic biologic mesh in ileal conduit has completed. The study involves patients wi…
-
CLINICAL_TRIALS trial_result · 2025-04-16Clinical Trial Update: CD155 in Bladder Cancer
A clinical trial evaluating CD155 in bladder cancer has completed.
-
CLINICAL_TRIALS trial_result · 2025-04-09Clinical Trial Update: Clinical Investigation of the Multi4 System [NA]
Clinical trial update announcing the completion of a clinical investigation of the Multi4 System for bladder cancer. The sponsor is listed a…